Desvenlafaxine Succinate

CAS 448904-47-0 23 current records 2 historicalSmall Molecule

Who holds supplier records for Desvenlafaxine Succinate? 23 organisations hold a current record for Desvenlafaxine Succinate: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (17), China (2), Canada (1) and Netherlands (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Desvenlafaxine Succinate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/desvenlafaxine-succinate

Reading the evidence

  • 23 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    17 of the 21 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 13 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (23)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Desvenlafaxine Succinate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India17China2Canada1Netherlands1Country not recorded for 2
Need Desvenlafaxine Succinate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Desvenlafaxine Succinate are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Desvenlafaxine Succinate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201728).

Chemical identity

IUPAC name
butanedioic acid;4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
Canonical SMILES
CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O
InChIKey
ORUUBRMVQCKYHB-UHFFFAOYSA-N
Synonyms
Desvenlafaxine succinate, Desvenlafaxine succinate anhydrous, Desvenlafaxine succinate hydrate, Desvenlafaxine succinate monohydrate, DVS-233, Dvs anhydrous, O-desmethyl venlafaxine succinate, O-desmethylvenlafaxine succinate, Pristiq, WY-45233, WY45233, RefChem:1083206

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action
Cytochrome P450 2D6 Inhibitors; Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Desvenlafaxine Succinate?

23 organisations hold an active US FDA Type II Drug Master File or a CEP for Desvenlafaxine Succinate: MSN LIFE SCIENCES PRIVATE LIMITED (India), Alembic Pharmaceuticals Limited (India), AMI LIFESCIENCES PRIVATE LTD (India), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), ATILUS PHARMA PRIVATE LTD and ATUL BIOSCIENCE LTD (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Desvenlafaxine Succinate Drug Master Files are active?

MSN LIFE SCIENCES PRIVATE LIMITED (DMF 31157, 30437), Alembic Pharmaceuticals Limited (DMF 22691), AMI LIFESCIENCES PRIVATE LTD (DMF 38066), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 37036), APITORIA PHARMA PRIVATE LTD (DMF 43897), Apotex Inc. (DMF 25777), ATILUS PHARMA PRIVATE LTD (DMF 44651) and ATUL BIOSCIENCE LTD (DMF 37571) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Desvenlafaxine Succinate records mean?

2 organisations have only inactive Type II DMFs for Desvenlafaxine Succinate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Desvenlafaxine Succinate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Desvenlafaxine Succinate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.